Scholar Rock Announces Design of Phase 3 Clinical Trial Evaluating Apitegromab

02 December 2021

Scholar Rock Announces Design of Phase 3 Clinical Trial Evaluating Apitegromab

Scholar Rock have released a community update announcing the design of SAPPHIRE - a Phase 3 clinical trial to further evaluate the safety and efficacy of apitegromab in those who are non-ambulatory and who have SMA Type 2 or Type 3.

In addition to this statement, Scholar Rock is planning to hold a webinar and answer questions submitted from the community detailing the SAPPHIRE study.

Read the Community Update